Noggin (NOG)

Noggin is a secreted, extracellular signaling protein encoded by the NOG gene that functions as a potent antagonist of multiple BMP family growth factors, important for embryonic patterning, neural tube formation, joint and skeletal development, and tissue differentiation. It exerts its effects by binding to specific BMPs, inhibiting their signaling and thereby tightly regulating cell fate decisions during embryogenesis and organogenesis. Loss-of-function mutations in the NOG gene cause various congenital disorders characterized by abnormal bone formation and joint fusion. While noggin is a key developmental regulator, it is not currently considered a direct therapeutic target nor a member of classical druggable receptor, enzyme, transporter, or channel families[1][2][3][4][5][7].

Other names

NOG proteinNOGNoggin protein

Noggin acts by binding to bone morphogenetic proteins (BMPs) such as BMP2, BMP4, BMP5, BMP6, BMP7, BMP13, and BMP14, preventing them from binding to their receptors on the cell surface, thereby inhibiting downstream TGF-β/BMP signaling pathways[1][2][3][4][5][7].